Morepen Laboratories Ltd
BSE:500288
Morepen Laboratories Ltd
BSE:500288
Price:
44.95
INR
-0.88%
Market Closed
Market Cap:
₹23B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Morepen Laboratories Ltd
BSE:500288
|
IN |
|
Pet Valu Holdings Ltd
OTC:PTVLF
|
CA |
|
L
|
LendingClub Corp
F:8LCA
|
US |
|
MorphoSys AG
XETRA:MOR
|
DE |
|
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
|
GR |
|
Argan Inc
NYSE:AGX
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
Sunrise New Energy Co Ltd
NASDAQ:EPOW
|
CN |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
MAD:LDA
|
ES |
|
V
|
Vicor Corp
SWB:VCV
|
US |
|
K
|
Kerry Group PLC
DUS:KRZ
|
IE |
|
Benitec Biopharma Inc
NASDAQ:BNTC
|
US |
|
Bank Tabungan Negara (Persero) Tbk PT
IDX:BBTN
|
ID |
|
Chemistree Technology Inc
OTC:CHMJD
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MOREPENLAB's stock price target?
Not Available
MOREPENLAB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Morepen Laboratories Ltd?
Projected CAGR
-15%
-15%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is -15%.
What is the Operating Income forecast for Morepen Laboratories Ltd?
Projected CAGR
-10%
-10%
The compound annual growth rate for Operating Income over the next 7 years is -10%.
What is the Net Income forecast for Morepen Laboratories Ltd?
Projected CAGR
-14%
-14%
The compound annual growth rate for Net Income over the next 7 years is -14%.
